Patent details

EP3215122 Title: STABLE PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY

Basic Information

Publication number:
EP3215122
PCT Application Number:
US2015059571
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157986092
PCT Publication Number:
WO2016073915
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STABLE PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY
French Title of Invention:
SOLUTION PROTEINIQUE STABLE CONTENANT UNE HAUTE CONCENTRATION DE ANTI-VEGF ANTICORPS
German Title of Invention:
STABILE PROTEINLÖSUNG ENTHALTEND EINE HOHEKONZENTRATION AN ANTI-VEGF-ANTIKÖRPER
SPC Number:

Dates

Filing date:
06/11/2015
Grant date:
13/08/2025
EP Publication Date:
13/09/2017
PCT Publication Date:
12/05/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/08/2025
EP B1 Publication Date:
13/08/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/11/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/08/2025
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
ALANI, Laman
Address:
United States (US)

2

Name:
ZHANG, Huixiang
Address:
United States (US)

3

Name:
ZENG, Yuhong
Address:
United States (US)

4

Name:
BORING, Charles
Address:
United States (US)

5

Name:
WAN, Li
Address:
United States (US)

6

Name:
KULSHRESHTHA, Alok
Address:
United States (US)

Priority

1

Priority Number:
201462076770 P
Priority Date:
07/11/2014
Priority Country:
United States (US)

2

Priority Number:
201462088061 P
Priority Date:
05/12/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61P 43/00; C07K 16/22; A61P 27/02; A61K 9/00; A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202533
Publication date:
13/08/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages